According to Royalty Pharma's latest financial reports the company's current earnings are C$2.23 Billion. In 2023 the company made an earning of C$2.63 Billion, an increase over its 2022 earnings that were of C$0.58 Billion. The earnings displayed on this page is the company's Pretax Income.